As of 2024-12-12, the Intrinsic Value of BioPharma Credit PLC (BPCR.L) is
1.31 USD. This BPCR.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 0.86 USD, the upside of BioPharma Credit PLC is
52.80%.
The range of the Intrinsic Value is 1.02 - 1.93 USD
BPCR.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
DCF (Growth 5y) |
1.02 - 1.93 |
1.31 |
52.8% |
DCF (Growth 10y) |
1.08 - 1.91 |
1.35 |
57.1% |
DCF (EBITDA 5y) |
0.72 - 0.85 |
0.80 |
-7.5% |
DCF (EBITDA 10y) |
0.86 - 1.04 |
0.95 |
10.6% |
Fair Value |
2.14 - 2.14 |
2.14 |
149.29% |
P/E |
0.86 - 1.03 |
0.93 |
8.3% |
EV/EBITDA |
0.55 - 1.03 |
0.70 |
-18.1% |
EPV |
0.97 - 1.26 |
1.12 |
29.7% |
DDM - Stable |
0.49 - 1.21 |
0.85 |
-1.2% |
DDM - Multi |
0.47 - 0.89 |
0.61 |
-28.9% |
BPCR.L Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
1,023.41 |
Beta |
0.28 |
Outstanding shares (mil) |
1,190.01 |
Enterprise Value (mil) |
986.26 |
Market risk premium |
5.48% |
Cost of Equity |
12.02% |
Cost of Debt |
5.00% |
WACC |
8.03% |